1. Home
  2. Live Updates
  3. Division of hematological malignancies

Live Breaking News & Updates on Division of hematological malignancies

Stay informed with the latest breaking news from Division of hematological malignancies on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Division of hematological malignancies and stay connected to the pulse of your community

Ajax Therapeutics Appoints Dr. David Steensma as Chief Medical Officer

NEW YORK--(BUSINESS WIRE)--Aug 23, 2023--

United-states , American , Kathryn-morris , David-steensma , Ross-levine , Martin-vogelbaum , Laurence-joseph-dineen , Edwardp-evans , Davidp-steensma , Harvard-medical-school , Translational-research , Division-of-hematological-malignancies

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Madrid , Spain , Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Alex-lobo , Milton-werner , Division-of-hematological-malignancies , Linkedin

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Press Release

Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ETBOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase Thera

Madrid , Spain , Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Alex-lobo , Milton-werner , Linkedin , Division-of-hematological-malignancies

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Madrid , Spain , Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Milton-werner , Division-of-hematological-malignancies , Linkedin , Twitter

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with...

Madrid , Spain , Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Alex-lobo , Milton-werner , Division-of-hematological-malignancies , Linkedin

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ETBOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase T...

Madrid , Spain , Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Alex-lobo , Milton-werner , Division-of-hematological-malignancies , Linkedin

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with...

Madrid , Spain , Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Alex-lobo , Milton-werner , Division-of-hematological-malignancies , Linkedin